National Marrow Donor Program Long-Term Donor Follow-Up

Status Completed

Clinical Trial Summary

Clinical Trial Description

This is an observational study of unstimulated bone marrow (BM) and filgrastim-mobilized peripheral blood stem cell (PBSC) donors. The primary goal is to evaluate the hypothesis that the incidence of targeted malignant, thrombotic and autoimmune disorders after unrelated hematopoietic stem cell donation are similar between unstimulated BM and filgrastim-mobilized PBSC donors. Donors will undergo biennial surveys until study completion. Cases of targeted disorders will be reviewed by the medical monitors to confirm the veracity of the report. ;

Study Design

Related Conditions & MeSH terms

Hematologic Neoplasms

Clinical Trial Details

NCT number	NCT01362179
Study type	Observational
Source	Center for International Blood and Marrow Transplant Research
Contact
Status	Completed
Phase
Start date	October 2010
Completion date	October 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03483194` - Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)	Phase 2/Phase 3
Recruiting	`NCT03735992` - Mind-body Medicine for Patients With Malignant Hematological Diseases	N/A
Recruiting	`NCT04959175` - Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies	Phase 1/Phase 2
Withdrawn	`NCT04275154` - Immunological Parameters, Neurocognitive Changes, Activity, & Driving Fitness in Patients Undergoing CAR-T Cell Therapy
Terminated	`NCT00957580` - Trial of Pimasertib in Hematological Malignancies	Phase 2
Completed	`NCT00997386` - Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States	Phase 2
Completed	`NCT00389428` - Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.	Phase 1
Completed	`NCT02193880` - Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)	N/A
Recruiting	`NCT00071045` - Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members
Not yet recruiting	`NCT05054231` - Immunological Profile for Patients Treated With CAR-T Cells	N/A
Completed	`NCT02650791` - Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study	Phase 3
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Terminated	`NCT03648372` - A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System	Phase 1/Phase 2
Recruiting	`NCT03320915` - Efficacy and Safety of High Dose Vitamin D Supplementation in Patients Undergoing HSCT	Phase 2
Recruiting	`NCT06422533` - Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients	N/A
Terminated	`NCT02895529` - A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy	Phase 4
Active, not recruiting	`NCT03680092` - Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation	Phase 2
Recruiting	`NCT03083327` - Prophylactic Early PN in HPT/BMT	N/A
Recruiting	`NCT03743480` - Early Palliative Care and Hematological Cancer Patients	N/A
Completed	`NCT02635984` - Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens	Phase 3

National Marrow Donor Program Long-Term Donor Follow-Up — LTDFU

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms